- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SEMNUR PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| Do | Semnur Pharmaceuticals, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.06. | Scilex Holding Company ("Scilex") Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities | 5 | GlobeNewswire (USA) | ||
| 04.06. | Scilex Holding Company ("Scilex") Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities | 7 | GlobeNewswire (USA) | ||
| 22.05. | Scilex Holding Company ("Scilex") Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026 | 292 | GlobeNewswire (Europe) | PALO ALTO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and... ► Artikel lesen | |
| 13.05. | Semnur Pharmaceuticals, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 23.04. | Semnur Pharmaceuticals kündigt zwei Wertpapierkaufverträge - keine Aktienausgabe erfolgt | 3 | Investing.com Deutsch | ||
| 23.04. | Semnur Pharmaceuticals, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17.03. | Semnur Pharmaceuticals, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.09.25 | Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding ... | 1.006 | GlobeNewswire (Europe) | PALO ALTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and... ► Artikel lesen | |
| 22.09.25 | Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination | 296 | GlobeNewswire (Europe) | Semnur's shares of common stock and warrants are expected to continue to trade on the OTC Markets under the ticker symbols "SMNR" and "SMNRW", respectively.Scilex (together with its affiliates) owns... ► Artikel lesen | |
| 21.08.25 | Scilex Holding Company Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc., and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at $16.00 per share | 256 | GlobeNewswire (Europe) | PALO ALTO, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and... ► Artikel lesen | |
| 13.08.25 | Scilex Holding Company Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc. | 482 | GlobeNewswire (Europe) | Denali's registration statement on Form S-4 declared effective by the Securities and Exchange CommissionExtraordinary general meeting of Denali Capital Acquisition Corp. shareholders to approve the... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MERCK & CO | 112,00 | -0,66 % | The Department of Health - Abu Dhabi: Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region | ABU DHABI, UAE, June 24, 2026 /PRNewswire/ -- As healthcare systems worldwide seek more resilient and efficient pathways to deliver innovative medicines, the Department of Health - Abu Dhabi... ► Artikel lesen | |
| UNITED THERAPEUTICS | 471,40 | -1,03 % | TD Cowen: United Therapeutics vor starkem Wachstum durch Pipeline-Erweiterung | ||
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026 | Northvale, New Jersey--(Newsfile Corp. - June 23, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products... ► Artikel lesen | |
| CHINA RESOURCES PHARMACEUTICAL | 0,505 | +3,48 % | CHINARES PHARMA (03320): INSIDE INFORMATION COMPLETION OF THE PUBLIC ISSUANCE OF THE THIRD TRANCHE OF 2026 CORPORATE BONDS IN THE PRC | ||
| CENTESSA PHARMACEUTICALS | 34,600 | 0,00 % | XFRA 260: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCENTESSA PHARMACEUTICALS... ► Artikel lesen | |
| BAYER | 47,000 | 0,00 % | Bayer und PORR werden für Produktionsanlage ausgezeichnet | ||
| MERCK KGAA | 145,65 | -0,92 % | DZ BANK stuft MERCK KGAA auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat die Einstufung für Merck KGaA auf "Kaufen" mit einem fairen Wert von 153 Euro belassen. Das Thema Künstliche Intelligenz (KI) sei für den Life-Science-Zuliefersektor... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,390 | 0,00 % | Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last? | ||
| JOURNEY MEDICAL | 6,620 | 0,00 % | Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 million Emrosi revenues were $6.3 million in the first quarter ended March 31, 2026 Cash position increased... ► Artikel lesen | |
| TRISALUS LIFE SCIENCES | 4,730 | 0,00 % | Canaccord reiterates TriSalus stock Buy rating after KOL event | ||
| NOVO NORDISK | 42,185 | +0,15 % | Novo Nordisk macht Druck: Wird das der ersehnte Befreiungsschlag? | Die Aktie des dänischen Pharmakonzerns Novo Nordisk ringt um Dynamik. Das Ende der Korrektur und die untere Trendwende scheinen greifbar. Gelingt es der Pharmaaktie nach der langwierigen Korrektur,... ► Artikel lesen | |
| ELI LILLY | 1.065,00 | +0,49 % | Why Eli Lilly Stock Jumped to a New All-Time High Today | ||
| LB PHARMACEUTICALS | 31,770 | -0,47 % | LB Pharmaceuticals stock rating maintained at buy by H.C. Wainwright | ||
| SHUTTLE PHARMACEUTICALS | 3,970 | -1,24 % | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site | Gaithersburg, Maryland--(Newsfile Corp. - June 26, 2026) - United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts recently acquired by Shuttle... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 16,550 | +0,49 % | Generate:Biomedicines: Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update | SOLAIRIA-1 AND SOLAIRIA-2 Phase 3 clinical trials for GB-0895 (anti-TSLP) continue to advance
Clinical trial sites activated for GB-4362 (MMAE neutralizer); first... ► Artikel lesen |
Das Unternehmen SEMNUR PHARMACEUTICALS INC kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SEMNUR PHARMACEUTICALS INC finden Sie auf Wallstreet Online.